News
Doctors are told to use hepatitis B vaccine sparingly because of global shortage
BMJ 2017; 358 doi: https://doi.org/10.1136/bmj.j3801 (Published 08 August 2017) Cite this as: BMJ 2017;358:j3801
- Zosia Kmietowicz
- The BMJ
Doctors have been told to use the hepatitis B vaccine sparingly, and only for people at highest immediate risk of infection, because of a global shortage.
Public Health England—with NHS England, the Department of Health, and the manufacturer GlaxoSmithKline—said that the measures are expected to last until the beginning of 2018.
Guidance from Public Health England says that the highest priority for vaccination are babies born to mothers infected with hepatitis B, because they have the highest risk of …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.